9 patents currently held
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Mar 2033. from the record
Of the 4 now held by other companies, 2 name Institut National de la Sante et de la Recherche Medicale Inserm as their current owner, and 2 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2033
Next term end
9
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2037 · High confidence
Also notable
Ends Mar 2033 · High confidence
Also notable
Ends Nov 2039 · High confidence
Device and System for Generating Ultrasonic Waves in a Target Region of a Soft Solid and Method for Locally Treating a Tissue
US 11,540,806
Cited by 38 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2037.
Method for Determining Optimized Parameters of a Device Generating a Plurality of Ultrasound Beams Focused in a Region of Interest
US 10,004,888
The most cited patent in this portfolio, cited by 50 later US patents, top 5% of utility patents granted in 2018 in our data. Protection runs to 2033.
Method and Apparatus for Determining Local Acoustic Field Intensity Within a Soft Solid
US 11,589,838
The newest of the three, granted 2023. It anchors the portfolio to 2039, later than anything else here.
Formerly held, still cited
Notable
Ends Jun 2040 · High confidence
Cited by 13 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2040.
now held by Centre Leon Berard
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,004,888 | Method for Determining Optimized Parameters of a Device Generating a Plurality of Ultrasound Beams Focused in a Region of Interest held by Institut National de la Santé et de la Recherche Médicale (Inserm), Universite Claude Bernard Lyon 1 and Centre Léon Bérard In force · High confidence | In force | High confidence | |
| US 9,895,439 | Combined Treatment with Netrin-1 Interfering Drug and Chemotherapeutic Drug held by Netris Pharma, Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique and Centre Léon Bérard In force · High confidence | In force | High confidence | |
| US 11,540,806 | Device and System for Generating Ultrasonic Waves in a Target Region of a Soft Solid and Method for Locally Treating a Tissue held by Institut National de la Sante et de la Recherche Medicale (Inserm), Université Claude Bernard Lyon 1 and Centre Léon-Bérard In force · High confidence | In force | High confidence | |
| US 11,555,191 | An Inhibitor for Use for Preventing And/Or Treating an Infection with Hepatitis B Virus held by Institut National de la Sante et de la Recherche Medicale (Inserm), Hospices Civils de Lyon, Centre Léon-Bérard, Centre National de la Recherche Scientifique and Université Claude Bernard Lyon 1 In force · High confidence | In force | High confidence | |
| US 12,162,932 | Combined Treatment with NETRIN-1 Interfering Drug and Immune Checkpoint Inhibitors Drugs In force · High confidence | In force | High confidence | |
| US 11,589,838 | Method and Apparatus for Determining Local Acoustic Field Intensity Within a Soft Solid held by Institut National de la Sante et de la Recherche Medicale (Inserm), Centre Léon-Bérard and Université Claude Bernard Lyon 1 In force · High confidence | In force | High confidence | |
| US 12,245,892 | Method and Apparatus for Imaging in Real Time the Propagation of a Mechanical Wave in an Acoustically Propagative Material held by Institut National de la Sante de la Recherche Medicale (Inserm), Université Claude Bernard Lyon and Centre Léon-Bérard In force · High confidence | In force | High confidence | |
| US 12,249,073 | Systems and Methods for Mesothelioma Feature Detection and Enhanced Prognosis or Response to Treatment In force · High confidence | In force | High confidence | |
| US 12,595,515 | Prognosis Method of Cancer held by Centre National de la Recherche Scientifique, Centre Léon Bérard, Institut National de la Santé et de la Recherche Médicale and Université Claude Bernard Lyon 1 In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 4 patents in force now held by others · 2 applications pending · 3 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.